Arachidonic acid facilitates experimental chronic osteomyelitis in rats.

AUTOR(ES)

Rissing, J P

RESUMO

Arachidonic acid was used as a facilitating agent in experimental rat Staphylococcus aureus osteomyelitis and compared with the more commonly used agent, sodium morrhuate. The injection of arachidonic acid or sodium morrhuate and S. aureus into rat tibiae caused increased quantitative bacterial bone counts, gross bone pathology, roentgenographic changes, and weight loss. The doses required to produce these changes appeared to be lower for arachidonic acid.

Documentos Relacionados

• Model of experimental chronic osteomyelitis in rats.
• Metabolic fate of arachidonic acid in hepatocytes of continuously endotoxemic rats.
• Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats.
• Inhibitory effects of arachidonic acid on muscarinic current response in single pancreatic acinar cells of rats.
• Control of inositol polyphosphate-mediated calcium mobilization by arachidonic acid in pancreatic acinar cells of rats.